Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

PolandBack to Poland

Clinical trials in Ostrowiec Swietokrzyski – page 4

81 clinical trials in Ostrowiec Swietokrzyski, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Ostrowiec Swietokrzyski at a glance
81
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

81 trials in Ostrowiec Swietokrzyski

Open in trial search

Chronic obstructive pulmonary disease

Not recruiting

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate Anhydrous
  • Sponsor:Chiesi Farmaceutici S.p.A.

Prophylaxis+1

Not recruiting

Study on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Salbutamol Sulfate
  • Sponsor:Glaxosmithkline Research & Development Limited

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Asthma

Not recruiting

Study on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Chronic obstructive pulmonary disease

Not recruiting

Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Vitiligo

Not recruiting

Study on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Pfizer Inc.

Hidradenitis

Not recruiting

A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BFB759
  • Sponsor:Bluefin Biomedicine Inc.

Hidradenitis

Not recruiting

A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Asthma

Not recruiting

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Ostrowiec Swietokrzyski

What the registry says about research in the country

01 Respiratory Conditions

Important clinical research focusing on asthma and COPD management, including trials evaluating new inhaler formulations and innovative treatments for severe cases.

  • Asthma control and exacerbation prevention
  • COPD treatment optimization
  • Bronchiectasis management

Studies include evaluation of triple therapy combinations and novel biological treatments for better disease control.

02 Dermatological Disorders

Comprehensive research into various skin conditions, with particular focus on atopic dermatitis, psoriasis, and other inflammatory skin disorders.

  • Moderate to severe plaque psoriasis
  • Atopic dermatitis treatments
  • Vitiligo and alopecia therapies

Trials examine both topical and systemic treatments, including novel biological therapies.

03 Cardiovascular Research

Innovative studies targeting atherosclerotic cardiovascular disease, focusing on prevention and treatment of major cardiovascular events.

  • Lipid-modifying therapies
  • Cardiovascular risk reduction
  • Prevention of major adverse cardiac events

Research includes evaluation of new compounds for managing cholesterol levels and preventing cardiovascular complications.

Back to PolandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.